Trinity Biotech PLC
NASDAQ:TRIB

Watchlist Manager
Trinity Biotech PLC Logo
Trinity Biotech PLC
NASDAQ:TRIB
Watchlist
Price: 1.22 USD -6.15% Market Closed
Market Cap: 11.5m USD
Have any thoughts about
Trinity Biotech PLC?
Write Note

Balance Sheet

Balance Sheet Decomposition
Trinity Biotech PLC

Current Assets 46m
Cash & Short-Term Investments 5.3m
Receivables 17.7m
Other Current Assets 23m
Non-Current Assets 48.4m
PP&E 3.9m
Intangibles 41.8m
Other Non-Current Assets 2.7m
Current Liabilities 25.8m
Accounts Payable 23.1m
Other Current Liabilities 2.7m
Non-Current Liabilities 98m
Long-Term Debt 91m
Other Non-Current Liabilities 7m

Balance Sheet
Trinity Biotech PLC

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
7
7
77
58
30
6
24
23
7
4
Cash
7
7
0
0
0
6
24
23
7
4
Cash Equivalents
0
0
77
58
30
0
0
0
0
0
Short-Term Investments
2
95
0
0
0
10
3
3
0
0
Total Receivables
26
21
24
22
26
22
25
16
16
13
Accounts Receivables
20
19
23
21
24
20
21
14
14
11
Other Receivables
6
1
1
1
2
2
3
2
2
2
Inventory
34
35
33
33
30
32
30
29
23
20
Other Current Assets
0
5
0
0
0
1
1
2
2
2
Total Current Assets
69
163
133
113
87
71
83
73
47
39
PP&E Net
18
21
13
6
5
9
9
6
6
2
PP&E Gross
18
21
0
0
0
9
9
6
6
2
Accumulated Depreciation
20
22
0
0
0
61
57
58
60
64
Intangible Assets
92
109
87
65
53
31
34
36
23
16
Goodwill
53
53
0
0
0
13
0
0
13
0
Note Receivable
0
1
0
0
0
0
0
0
0
0
Other Long-Term Assets
11
18
15
9
6
6
4
4
4
2
Other Assets
53
53
0
0
0
13
0
0
13
0
Total Assets
243
N/A
364
+50%
250
-31%
193
-23%
151
-21%
131
-13%
130
-1%
119
-9%
92
-23%
59
-35%
Liabilities
Accounts Payable
9
8
25
21
17
8
10
7
6
5
Accrued Liabilities
11
10
0
0
0
9
10
8
9
8
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
0
0
0
2
2
85
2
2
Other Current Liabilities
1
2
0
0
0
0
5
0
0
0
Total Current Liabilities
22
20
25
21
18
19
27
100
17
15
Long-Term Debt
0
93
96
95
82
100
99
14
70
66
Deferred Income Tax
21
25
18
11
7
7
5
5
5
2
Other Liabilities
2
12
1
1
1
0
1
0
2
1
Total Liabilities
46
N/A
150
+227%
141
-6%
127
-10%
107
-16%
126
+18%
133
+5%
119
-10%
94
-21%
83
-12%
Equity
Common Stock
1
1
1
1
1
1
1
1
2
2
Retained Earnings
195
214
91
48
55
16
11
13
27
49
Additional Paid In Capital
12
16
16
16
16
16
16
16
46
47
Treasury Stock
7
7
0
0
29
25
25
25
25
25
Other Equity
5
9
0
0
0
4
5
5
1
1
Total Equity
197
N/A
214
+9%
109
-49%
65
-40%
44
-32%
5
-89%
2
N/A
0
+86%
2
-582%
24
-1 001%
Total Liabilities & Equity
243
N/A
364
+50%
250
-31%
193
-23%
151
-21%
131
-13%
130
-1%
119
-9%
92
-23%
59
-35%
Shares Outstanding
Common Shares Outstanding
18
19
19
19
19
19
19
19
33
31

See Also

Discover More